Skip to content

Finding an Optimal Latency for Paired Associative Stimulation in People With Chronic Stroke

Effect of Different Interpulse Intervals of Paired Associative Stimulation on Cortical Excitability in People With Chronic Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02188420
Enrollment
4
Registered
2014-07-11
Start date
2014-09-30
Completion date
2016-12-31
Last updated
2025-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

PAS, TMS, Stroke, Paired Associative Stimulation, Transcranial Magnetic Stimulation

Brief summary

After a stroke, there is an exaggerated inhibitory influence from the non-stroke hemisphere to the stroke hemisphere. Brain stimulation using repetitive transcranial magnetic stimulation (rTMS) to the non-stroke hemisphere can decrease this inhibition. Paired Associative Stimulation (PAS) may be a more effective way to produce this same inhibition, as shown in healthy subjects. However, it is not known whether this will translate to people with stroke. PAS consists of a peripheral nerve stimulus paired a short time later with a cortical stimulus to change the excitability within the brain. Thus the investigators will apply PAS to people with stroke, but the investigators need to first determine the most effective interpulse interval (IPI) between the peripheral and cortical stimuli. Our research question is which of three different IPIs is most effective in changing the excitability of the brain. The purpose of this study is to determine the optimal IPI between a peripheral nerve pulse and a cortical stimulus that will be most effective in changing excitability of the brain in people with chronic stroke. The investigators hypothesize that the cortical excitability of the nonstroke hemisphere will be most inhibited with the latency-5ms condition.

Detailed description

Numerous PAS studies have been done in healthy subjects and all have been done safely. The proper interpulse interval in healthy individuals between the peripheral nerve stimulus and the cortical stimulus is known to be latency-5ms. However, this may be different in individuals with stroke. Specific Aim: what is the optimal interpulse interval to achieve the maximum inhibitory effect in the nonstroke hemisphere? We will recruit three subjects with chronic stroke. Electroencephalography (EEG) will be used to determine the latency between the peripheral nerve stimulus and the sensory evoked potential in each subject. We will then assess the following IPIs on each subject in a random order: latency - 3ms, -5ms and -7ms. There will be a fourth condition of latency + 100ms (known to have no effect) to be used as a control. The washout period will be at least one week between each of these conditions. The optimal IPI will be determined from these tests by comparing single pulse transcranial magnetic stimulation (TMS) measures for cortical excitability. Prior to each treatment, each subject will receive 20 single pulse cortical stimuli to serve as pretest data. The post tests for each condition will consist of 20 single pulse cortical stimuli at 0, 5, 10, 15, 30, 45 and 60 minutes after the PAS condition. Data analysis will consist of a single-subject analysis with the two standard deviation bandwidth method of each post-test compared to pre-test. We hypothesize that there will be no adverse advents and that this optimal IPI will be latency-5ms.

Interventions

DEVICETranscranial Magnetic Stimulation will be applied to the primary motor cortex at the interstimulus interval of (Latency - 3ms)

Transcranial Magnetic Stimulation will be applied to the primary motor cortex at the interstimulus interval of (Latency - 3ms) where latency refers to the amount of time for the arrival of a sensory evoked potential as determined by EEG.

DEVICETranscranial Magnetic Stimulation will be applied to the primary motor cortex at the interstimulus interval of (Latency - 5ms)

Transcranial Magnetic Stimulation 5ms

DEVICEranscranial Magnetic Stimulation will be applied to the primary motor cortex at the interstimulus interval of (Latency - 7ms)

Transcranial Magnetic Stimulation 7ms

DEVICETranscranial Magnetic Stimulation Time 100ms

Active Compator

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DEVICE_FEASIBILITY
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* stroke (ischemic or hemorrhagic) of greater than 6 months duration * impairment in the paretic hand * over 18 years old * male or female * on mini mental status exam must have score of 22 or higher * must have elicitable motor evoked potential (MEP)

Exclusion criteria

* seizure within the past two years * receptive aphasia * epileptogenic medication * major psychiatric disorder * other interfering comorbidities * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change in Cortical Excitability Using Single TMS PulsesChange from pretest (immediately prior to PAS application) to posttest which will occur over the 60 minutes that follow PAS application.Assess average size of 20 motor evoked potentials via electromyography (EMG) signal resulting from single TMS pulses to the motor cortex. Measurements taken before and after paired associative stimulation treatment at each session.

Countries

United States

Participant flow

Pre-assignment details

There were no significant events or excluded participants prior to being assigned an intervention order

Participants by arm

ArmCount
All Study Participants
This is a cross-over study; all participants completed all four treatment arms.
4
Total4

Baseline characteristics

CharacteristicAll Study Participants
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
4 Participants
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
2 Participants
Sex: Female, Male
Male
2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 40 / 40 / 40 / 4
other
Total, other adverse events
0 / 40 / 40 / 40 / 4
serious
Total, serious adverse events
0 / 40 / 40 / 40 / 4

Outcome results

Primary

Change in Cortical Excitability Using Single TMS Pulses

Assess average size of 20 motor evoked potentials via electromyography (EMG) signal resulting from single TMS pulses to the motor cortex. Measurements taken before and after paired associative stimulation treatment at each session.

Time frame: Change from pretest (immediately prior to PAS application) to posttest which will occur over the 60 minutes that follow PAS application.

ArmMeasureValue (MEAN)Dispersion
Latency Minus 3msChange in Cortical Excitability Using Single TMS Pulses-.07667 Log10(microvolts)Standard Deviation 0.06184
Latency Minus 5msChange in Cortical Excitability Using Single TMS Pulses0.11 Log10(microvolts)Standard Deviation 0.06164
Latency Minus 7msChange in Cortical Excitability Using Single TMS Pulses-.05667 Log10(microvolts)Standard Deviation 0.2625
Latency Plus 100msChange in Cortical Excitability Using Single TMS Pulses.1233 Log10(microvolts)Standard Deviation 0.15173

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026